EssilorLuxottica Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €270.50 High: €275.30
on September 23, 2025

52 Week Range

Low: €202.10 High: €298.00
on September 23, 2024
on February 14, 2025

All-Time High: €298.00 on February 10, 2025

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €126.5B
EPS i 5.15
P/E Ratio (TTM) i 53.38
Forward P/E i 35.84
P/B Ratio i 3.35
PEG Ratio i 35.84
Div. Yield i 1.64%
ROE i 6.44%
Beta i 0.748
Debt to Equity i 36.58

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i 14.25%
Profit Margin i 8.74%

Returns and Earnings

Return on Assets (TTM) i 3.58%
Return on Equity (TTM) i 6.44%
EBITDA i €6.6B
Net Income (TTM) i €2.4B

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €59.65
Quarterly Revenue Growth (YoY) i 5.50%
Quarterly Earnings Growth (YoY) i 1.60%

Dividend Information

Last 12-Month Dividend i €3.95
Current Dividend Yield i 1.64%
3-Year Average Dividend Yield i 1.79%
3-Year Average Annual Dividend i €3.71
3-Year Total Dividends i €11.13
Ex-Dividend Date i May 7, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
EssilorLuxottica EL 126.54B Large-cap1.40%1.93%14.00%1.44%17.16%28.58%95.51%131.56%
Sartorius Stedim DIM 18.74B Large-cap6.79%7.06%-3.93%-3.95%1.13%-2.40%-40.96%-38.14%
Amplitude Surgical AMPLI 299.85M Mid-cap0.00%0.00%0.81%2.48%93.75%94.97%115.28%191.08%
Safe Orthopaedics ALSAF 218.94M Mid-cap0.00%0.00%0.00%23,900.00%3,328.57%0.00%0.00%0.00%
Crossject S.A ALCJ 86.86M Small-cap0.00%1.91%-1.84%-9.09%-28.57%-33.33%-41.18%-36.25%
Visiomed Group SA ALVMG 70.01M Small-cap13.64%19.05%38.89%25.00%47.06%19.05%-41.86%-73.40%

Ownership & Short Interest

Insider Ownership i 36.89%
Institutional Ownership i 29.29%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 440K
Average 90-Day Volume i 397K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, EssilorLuxottica reached a high of €298.00 (on February 14, 2025) and a low of €202.10 (on September 23, 2024).
Curious about EssilorLuxottica's size and valuation? Its market capitalization stands at 126.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is 53.38, and the forward P/E (looking ahead) is 35.84.
Yes, EssilorLuxottica is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.64%, and the company has paid an average of €3.71 per share annually over the past 3 years.

When looking at EssilorLuxottica, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Sartorius Stedim
DIM
18.74BHealthcareMedical Instruments & Supplies-2.40%-40.96%
Amplitude Surgical
AMPLI
299.85MHealthcareMedical Instruments & Supplies94.97%115.28%
Safe Orthopaedics
ALSAF
218.94MHealthcareMedical Instruments & Supplies0.00%0.00%
Crossject S.A
ALCJ
86.86MHealthcareMedical Instruments & Supplies-33.33%-41.18%
Visiomed Group SA
ALVMG
70.01MHealthcareMedical Instruments & Supplies19.05%-41.86%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of EssilorLuxottica's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.44%, the Debt to Equity ratio from the most recent quarter is 36.58, and its Gross Profit Margin stands at N/A.
Looking at EssilorLuxottica's growth, its revenue over the trailing twelve months (TTM) was €27B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.50%, and quarterly earnings saw a YoY growth of 1.60%.
Wondering who owns EssilorLuxottica stock? Company insiders (like executives and directors) hold about 36.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 29.29%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.